281 related articles for article (PubMed ID: 25108321)
1. Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.
Górska A; Sloderbach A; Marszałł MP
Trends Pharmacol Sci; 2014 Sep; 35(9):442-9. PubMed ID: 25108321
[TBL] [Abstract][Full Text] [Related]
2. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.
Mislin GL; Schalk IJ
Metallomics; 2014 Mar; 6(3):408-20. PubMed ID: 24481292
[TBL] [Abstract][Full Text] [Related]
3. Building a Trojan Horse: Siderophore-Drug Conjugates for the Treatment of Infectious Diseases.
Gumienna-Kontecka E; Carver PL
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855108
[TBL] [Abstract][Full Text] [Related]
4. Siderophores as drug delivery agents: application of the "Trojan Horse" strategy.
Möllmann U; Heinisch L; Bauernfeind A; Köhler T; Ankel-Fuchs D
Biometals; 2009 Aug; 22(4):615-24. PubMed ID: 19214755
[TBL] [Abstract][Full Text] [Related]
5. A Trojan-Horse Strategy Including a Bacterial Suicide Action for the Efficient Use of a Specific Gram-Positive Antibiotic on Gram-Negative Bacteria.
Schalk IJ
J Med Chem; 2018 May; 61(9):3842-3844. PubMed ID: 29683323
[TBL] [Abstract][Full Text] [Related]
6. Targeting human pathogenic bacteria by siderophores: A proteomics review.
Ferreira D; Seca AML; C G A D; Silva AMS
J Proteomics; 2016 Aug; 145():153-166. PubMed ID: 27109355
[TBL] [Abstract][Full Text] [Related]
7. Overcoming antibiotic resistance: Is siderophore Trojan horse conjugation an answer to evolving resistance in microbial pathogens?
Dhusia K; Bajpai A; Ramteke PW
J Control Release; 2018 Jan; 269():63-87. PubMed ID: 29129658
[TBL] [Abstract][Full Text] [Related]
8. Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates.
Ghosh A; Ghosh M; Niu C; Malouin F; Moellmann U; Miller MJ
Chem Biol; 1996 Dec; 3(12):1011-9. PubMed ID: 9000006
[TBL] [Abstract][Full Text] [Related]
9. Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases.
Tonziello G; Caraffa E; Pinchera B; Granata G; Petrosillo N
Infect Dis Rep; 2019 Sep; 11(2):8208. PubMed ID: 31649808
[TBL] [Abstract][Full Text] [Related]
10. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.
Wencewicz TA; Long TE; Möllmann U; Miller MJ
Bioconjug Chem; 2013 Mar; 24(3):473-86. PubMed ID: 23350642
[TBL] [Abstract][Full Text] [Related]
11. Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry.
Khasheii B; Mahmoodi P; Mohammadzadeh A
Microbiol Res; 2021 Sep; 250():126790. PubMed ID: 34098495
[TBL] [Abstract][Full Text] [Related]
12. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.
Wencewicz TA; Möllmann U; Long TE; Miller MJ
Biometals; 2009 Aug; 22(4):633-48. PubMed ID: 19221879
[TBL] [Abstract][Full Text] [Related]
13. TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.
Luscher A; Moynié L; Auguste PS; Bumann D; Mazza L; Pletzer D; Naismith JH; Köhler T
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555629
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA.
Ferguson AD; Braun V; Fiedler HP; Coulton JW; Diederichs K; Welte W
Protein Sci; 2000 May; 9(5):956-63. PubMed ID: 10850805
[TBL] [Abstract][Full Text] [Related]
15. Uptake Mechanisms and Regulatory Responses to MECAM- and DOTAM-Based Artificial Siderophores and Their Antibiotic Conjugates in
Fritsch S; Gasser V; Peukert C; Pinkert L; Kuhn L; Perraud Q; Normant V; Brönstrup M; Schalk IJ
ACS Infect Dis; 2022 Jun; 8(6):1134-1146. PubMed ID: 35500104
[TBL] [Abstract][Full Text] [Related]
16. Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum Gram-negative antibiotics.
Lin YM; Ghosh M; Miller PA; Möllmann U; Miller MJ
Biometals; 2019 Jun; 32(3):425-451. PubMed ID: 30919118
[TBL] [Abstract][Full Text] [Related]
17. Experimental Methods for Evaluating the Bacterial Uptake of Trojan Horse Antibacterials.
Southwell JW; Black CM; Duhme-Klair AK
ChemMedChem; 2021 Apr; 16(7):1063-1076. PubMed ID: 33238066
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens.
Guo C; Nolan EM
Acc Chem Res; 2024 Apr; 57(7):1046-1056. PubMed ID: 38483177
[TBL] [Abstract][Full Text] [Related]
19. An overview of recent progress in siderophore-antibiotic conjugates.
Kong H; Cheng W; Wei H; Yuan Y; Yang Z; Zhang X
Eur J Med Chem; 2019 Nov; 182():111615. PubMed ID: 31434038
[TBL] [Abstract][Full Text] [Related]
20. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.
Page MGP
Clin Infect Dis; 2019 Nov; 69(Suppl 7):S529-S537. PubMed ID: 31724044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
